Gauging the Impact of High-Impact Drugs in Workers’ Comp
An Overlooked Essential: Hospital Discharge Planning in Workers’ Compensation
In a recent article, Jim Begg, Vice President of National Accounts for Apricus, highlights the critical role of effective discharge planning in helping patients recover swiftly and safely.
Bridging the Gap for New Adjusters with Innovative Tools
Streamline your claims process and support your team with our cutting-edge solutions.
New Trends in Opioids and Pain Management
Despite decreases in utilization and cost per claim, opioids remain the No. 1 drug class in Enlyte’s 2024 Drug Trends Report. However, due to concerns with safety and overutilization, increased focus on usage guidelines as well as alternatives to pain management are gaining momentum — including those whose active ingredients drive from things you might not imagine, like pufferfish, cacti and chili peppers. Enlyte’s Nikki Wilson explores this and more in our Part 3 drug trends analysis.
Ask The Pharmacist: GLP-1 Drugs in Workers’ Compensation
Glucagon-like peptide 1 (GLP-1) receptor agonists medications, originally designed for diabetes management, have skyrocketed in popularity over the past year as effective drugs for weight loss and obesity.
The Coventry VIP Program
In this article, Jill Harris, SVP, Network Operations outlines how the Coventry VIP Program benefits all parties. She provides an overview and the components of the program's offerings, illustrating how investing in provider relationships serves as a foundation for a robust network strategy.
Looking Beyond the Numbers of Enlyte’s Medical Price Index
In this quarter’s Enlyte Executive Insight, Michele Hibbert, senior vice president of regulatory compliance management, discusses the latest results from Enlyte’s medical price index and how it impacts the industry.